1. What is the penalty for a person who obstructs an Inspector in the exercise of any power conferred upon him under the Act?
2. Which authority may authorize a Federal Inspector to disclose information acquired during official duties?
3. Under what conditions is contract manufacture permissible?
4. What is the role of the Appellate Board under The Drug Regulatory Authority of Pakistan Act, 2012?
5. What is the maximum time limit for submieng an appeal to the Appellate Board after receiving a decision?
6. What is the primary function of the Federal Drug Laboratory as stated in the rules?
7. The Central Research Fund fee collected by the Authority will be utilized for:
8. What is the purpose of The Drug Regulatory Authority of Pakistan Act, 2012?
9. In what circumstances shall a drug not be deemed misbranded or adulterated?
10. What type of containers are ophthalmic solutions and suspensions required to be contained in?
11. Under what circumstance can an exporter withdraw a batch of drugs from export after being informed by the licensing authority?
12. What does an Inspector require from a person during a search or seizure under Schedule-V?
13. What is the purpose of the license to manufacture drugs for experimental purposes?
14. What degree qualifications are required for the competent technical staff involved in the manufacture of drugs by way of basic or semi-basic manufacture?
15. What is the definition of "promotion" for the purposes of Schedule G of 1976 Rules?
16. What substances are NOT included in the definition of "Drug" under Schedule-I?
17. Where should one portion of a sample taken by an Inspector be sent for test and analysis?
18. Who has the authority to make rules for carrying out the purposes of the DRAP Act 2012?
19. When does an Inspector need to divide a sample into three portoons instead of four?
20. In which situations may the Registration Board provisionally register a drug for a period of two years?
21. Under Schedule-II, what is allowed in terms of distributing therapeutic goods as samples?
22. What is the punishment for a person who exports, imports, manufactures for sale, or sells any spurious therapeutic good or any unregistered therapeutic good?
23. What is the purpose of Form 6?
24. Who has the authority to make rules for carrying out the purposes of the DRAP Act 2012?
25. When does an Inspector need to divide a sample into three portoons instead of four?
26. What kind of offense is non-cognizable under the Drugs Act 1976?
27. What is the role of the Quality Control Department in the manufacturing process?
28. Who is responsible for carrying out the audit of the Authority's accounts?
29. What is the penalty for a person who fails to provide information requested by the Authority?
30. What action should the Authority take in response to objections raised by the Auditor-General?
31. What condition must be met for an application for renewal of a licence to be entertained?
32. Who has the authority to establish the Drug Regulatory Authority of Pakistan?
33. What is the purpose of a separate application for manufacturing drugs on more than one set of premises?
34. In case of inconsistency between the provisions of the DRAP Act and any other law, what takes precedence?
35. According to the Drug Licensing, Registering & Advertisement rules 1976, what type of information should advertisements to physicians and health-related professionals be consistent with?
36. What are "Medicated Cosmetics" under Schedule-I?
37. What is the penalty for a person who fails to provide information requested by the Authority?
38. What is the definition of "Biological Drugs (Ready-to-fill form)" under Schedule-I?
39. Who can revoke an order passed under Section 32 of the DRAP Act, 2012?
40. What is the punishment for violating any prohibitions specified in Schedule-II of the DRAP Act?
41. Who has the power to institute a prosecution for a contravention of any provision of the DRAP Act, 2012, and The Drugs Act, 1976?
42. What is the purpose of an "airlock" in pharmaceutical manufacturing?
43. Which authority is responsible for issuing licences to manufacture drugs by way of repacking under section 18 of ordinance in a province?
44. Which of the following is NOT included in the definition of "Biologicals" under Schedule-I?
45. What is the meaning of "Reference Biotherapeutic Product (RBP)" under ScheduleI?
46. What is the fee for the renewal of registration of a new drug?
47. What is the purpose of the Central Research Fund mentioned in the Drugs Licensing, Registering & Advertising Rules 1976?
48. What is the condition under which printing of labeling for therapeutic goods is allowed under Schedule-II?
49. Who is responsible for maintaining records of quarterly production and disposal of a drug?
50. Under what conditions can the aid from the research fund be withdrawn and a clinical trial terminated?
51. How long do members, other than ex-officio members, of the Appellate Board hold office for initially?
52. Which Division is responsible for the evaluation, assessment, and registration of pharmaceutical drugs for human beings and animals?
53. What is the purpose of the Drugs (Research) Rules, 1978?
54. What is the purpose of the criteria regarding medical representatives?
55. The Drugs Act, 1976 extends to which of the following areas?
56. For drugs other than those falling under specific categories, whose approval is required for the specifications?
57. Which power of the Inspector requires specific authorization by the Government?
58. Who is considered an "investigator" under the Drugs (Research) Rules?
59. What is the short title of the rules that govern the Drugs Appellate Board?
60. What is the penalty for selling a drug in the finished form over and above the maximum retail price fixed by the Federal Government?
61. What is the purpose of Form 10 in the export of drugs?
62. Who may physically inspect an imported consignment, draw samples, and order the importer not to sell or dispose of the drug for a specific period?
63. The Authority shall levy and collect fees for its functions at rates determined by:
64. What is the fee for submitting an appeal to the Appellate Board, as mentioned in the rules?
65. What labeling requirements apply to drugs manufactured for experimental purposes?
66. What is the punishment for violating any prohibitions specified in Schedule-II of the DRAP Act?
67. Which of the following offenses punishable under Schedule-III is non-cognizable?
68. Under what condition can finished drugs be imported?
69. What is the commencement date for the Drugs (Specifications) Rules, 1978?
70. What is the main duty of a Federal Inspector?
71. What is the role of the Quality Control Department in the manufacturing process?
72. What does the term "Advertise" mean under Schedule-II?
73. What does the term "Advertise" mean under Schedule-II?
74. According to the Drugs (Specifications) Rules, 1978, what is the requirement for ophthalmic ointments?
75. What is the purpose of the Committee on Drugs Evaluation?
76. According to the schedule in the Drugs (Specifications) Rules, what specifications should drugs bear that reference publications specified under sub-clause (ii) of clause (z) of Section 3?
77. What are "Medicated Cosmetics" under Schedule-I?
78. Which of the following statements about advertisement material is NOT true?
79. What does an Inspector require from a person during a search or seizure under Schedule-V?
80. Which of the following actions related to therapeutic goods is PROHIBITED under Schedule-II?
81. What stage of investigation on human beings involves determining safety, effectiveness, and common side effects of a drug?
82. Who serves as the ex-officio Chairman of the Appellate Board?
83. What is the penalty for selling a drug in the finished form over and above the maximum retail price fixed by the Federal Government?
84. Which of the following criteria should promotional claims about drugs adhere to?
85. Within what time frame should the Authority submit its annual report to the Federal Government?
86. Which type of research involves intervention, treatment, or medication programs using human subjects?
87. Which of the following actions related to therapeutic goods is PROHIBITED under Schedule-II?
88. Which of the following is NOT considered as "Therapeutic goods" under the Act?
89. What is the duration of a license to import drugs, unless suspended or canceled?
90. Who has the authority to physically inspect consignments of exported drugs and draw samples for testing?
91. Which court shall try an offense punishable under the DRAP Act, 2012, and The Drugs Act, 1976?
92. What authority is responsible for inspecting and regulaying the manufacturing of drugs under 1976 rules?
93. What is the penalty for a subsequent offense under Clause (1) of Schedule-III?
94. What is the procedure for appealing the suspension or cancellation of a license under Drugs Import & Export Rules 1976?
95. What is the purpose of the Drug Regulatory Authority of Pakistan Fund?
96. What is the maximum duration for which the approval of an advertisement under sub-rule (1) is valid?
97. If any difficulty arises in giving effect to any provision of the DRAP Act, who has the authority to remove the difficulty?
98. What is the consequence of violating the conditions of a license to import drugs or the provisions of the Act?
99. In which circumstances may the Registration Board register a drug on its own motion?
100. What is the penalty for giving a false warranty in respect of any therapeutic good or applying a warranty given for another therapeutic good?